相关实验视频

Updated: May 27, 2025

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

生物 - 胺 - 敏感的基底腺疾病:一个病例报告

Jonathan Tse¹, Asem Abu-Qamar¹, Omar Youssef¹

¹Western Michigan University Homer Stryker School of Meidcine, Kalamazoo, MI, USA.

Case reports in neurology

|February 21, 2025

概括

由于症状的变化,对生物胺敏感的基底腺癌 (BTBGD) 的诊断具有挑战性. 该病例发现了新的SLC19A3变异,表明需要进一步研究以改进这种罕见的神经代谢障碍的基因测试.

科学领域:

神经学神经学
遗传学是一个遗传学.
代谢障碍代谢障碍代谢障碍

背景情况:

生物胺响应性基底腺疾病 (BTBGD) 是一种罕见的,自体递归的神经代谢疾病.
可变和多样化的表型特征可能会使BTBGD诊断复杂化.
早期用胺和生物素治疗对于管理BTBGD至关重要.

研究的目的:

在患有新型SLC19A3变异的婴儿中报告BTBGD病例.
突出BTBGD的诊断挑战和基因测试的重要性.
强调需要对具有不确定的意义的SLC19A3变体进行进一步研究.

主要方法:

一个7个月大的女婴的临床表现和实验室评估.
大脑MRI评估神经参与.
全基因组测序以识别SLC19A3基因中的遗传变异.

主要成果:

患者表现出易怒,行为改变,昏迷和乳酸性酸性.
核磁共振扫描显示,在基底和体中,扩散受限.
在SLC19A3中,双变异,包括误解变异和内部删除,被确定为具有不确定的意义的变异.
随着生物和胺补充剂的使用,症状得到缓解,支持BTBGD的诊断.

结论:

基因检测至关重要,但需要进一步细化BTBGD诊断.
在这种情况下,发现了具有不确定的意义的新型SLC19A3变异.
需要进一步的研究来确定SLC19A3变体的致病性,并提高BTBGD的诊断准确性.

关键词:

生物 - 胺 - 基底性腺疾病案例报告案例报告脑病变是一种脑病变.代谢障碍是一种代谢障碍.

更多相关视频

Improving the Application of High Molecular Weight Biotinylated Dextran Amine for Thalamocortical Projection Tracing in the Rat

Improving the Application of High Molecular Weight Biotinylated Dextran Amine for Thalamocortical Projection Tracing in the Rat

Published on: April 12, 2018

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Published on: January 22, 2014

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...